Cargando…

Transmission and clinical characteristics of asymptomatic patients with SARS-CoV-2 infection

The 2019 novel coronavirus disease, SARS-CoV-2, is now spreading globally and is characterized by person-to-person transmission. However, it has recently been found that individuals infected with SARS-CoV-2 can be asymptomatic, and simultaneously a source of infection in others. The viral load detec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Jie, Liu, Shousheng, Zhuang, Likun, Chen, Lizhen, Dong, Mengzhen, Zhang, Jie, Xin, Yongning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2020
Materias:	Special Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291769/ http://dx.doi.org/10.2217/fvl-2020-0087

Ejemplares similares

ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19
por: Dong, Mengzhen, et al.
Publicado: (2020)

Lipid-induced DRAM recruits STOM to lysosomes and induces LMP to promote exosome release from hepatocytes in NAFLD
por: Zhang, Jie, et al.
Publicado: (2021)

DRAM1 increases the secretion of PKM2-enriched EVs from hepatocytes to promote macrophage activation and disease progression in ALD
por: Tan, Jie, et al.
Publicado: (2021)

Asymptomatic Transmission of SARS-CoV-2 on Evacuation Flight
por: Bae, Sung Hwan, et al.
Publicado: (2020)

Control of SARS-CoV-2 transmission in orthodontic practice
por: Guo, Yongwen, et al.
Publicado: (2020)

Interpretation of laboratory tests for prevention of the SARS-CoV-2 transmission
por: Masui, Kenichi
Publicado: (2020)

The association between SNPs rs1800591 and rs3816873 of the MTTP gene and nonalcoholic fatty liver disease: A meta-analysis
por: Tan, Jie, et al.
Publicado: (2020)

Asymptomatic transmission of SARS‐CoV‐2 and implications for mass gatherings
por: Wong, Justin, et al.
Publicado: (2020)

Viral transmission in asymptomatic cases of SARS-CoV-2 infection
por: Grall, Isabelle, et al.
Publicado: (2021)

The challenge of asymptomatic SARS-CoV-2 transmission in care homes
por: Belmin, Joël, et al.
Publicado: (2021)

Longitudinal Characteristics of T Cell Responses in Asymptomatic SARS-CoV-2 Infection
por: Yang, Jingyi, et al.
Publicado: (2020)

Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis
por: Ma, Xuefeng, et al.
Publicado: (2020)

Roles and regulatory mechanisms of miR-30b in cancer, cardiovascular disease, and metabolic disorders (Review)
por: Zhang, Qing, et al.
Publicado: (2021)

SARS‐CoV‐2 asymptomatic and symptomatic patients and risk for transfusion transmission
por: Corman, Victor M., et al.
Publicado: (2020)

Asymptomatic and presymptomatic transmission of SARS-CoV-2: A systematic review
por: Savvides, Christina, et al.
Publicado: (2020)

Viral Transmission and Clinical Features in Asymptomatic Carriers of SARS-CoV-2 in Wuhan, China
por: Tan, Fen, et al.
Publicado: (2020)

Serum 25-hydroxyvitamin D levels and the risk of non-alcoholic fatty liver: A two-sample Mendelian randomization study
por: Sheng, Qi, et al.
Publicado: (2022)

Clinical Characteristics of Asymptomatic Patients with SARS-CoV-2 in Zhejiang: An Imperceptible Source of Infection
por: Dai, Wei, et al.
Publicado: (2020)

Asymptomatic carriage and transmission of SARS-CoV-2: What do we know?
por: Lee, Susan, et al.
Publicado: (2020)

Analysis of Asymptomatic and Presymptomatic Transmission in SARS-CoV-2 Outbreak, Germany, 2020
por: Bender, Jennifer K., et al.
Publicado: (2021)

Modeling the SARS-CoV-2 parallel transmission dynamics: Asymptomatic and symptomatic pathways
por: Chowdhury, S.M.E.K., et al.
Publicado: (2022)

SARS-CoV-2 Variants and Vaccines
por: Krause, Philip R., et al.
Publicado: (2021)

Corrigendum to “Clinical Characteristics of Asymptomatic Patients with SARS-CoV-2 in Zhejiang: An Imperceptible Source of Infection”
por: Dai, Wei, et al.
Publicado: (2023)

Characteristics of asymptomatic patients with SARS-CoV-2 infection in Jinan, China
por: Ma, Yan, et al.
Publicado: (2020)

Clinical characteristics and infectivity of asymptomatic carriers of SARS-CoV-2 (Review)
por: Zhang, Wanying, et al.
Publicado: (2021)

Asymptomatic SARS-CoV-2 infection
por: Ooi, Eng Eong, et al.
Publicado: (2020)

Association between the LRP5 rs556442 gene polymorphism and the risks of NAFLD and CHD in a Chinese Han population
por: Han, Dongli, et al.
Publicado: (2022)

Relationship between AGT rs2493132 polymorphism and the risk of coronary artery disease in patients with NAFLD in the Chinese Han population
por: Dong, Mengzhen, et al.
Publicado: (2021)

The contribution of asymptomatic SARS-CoV-2 infections to transmission on the Diamond Princess cruise ship
por: Emery, Jon C, et al.
Publicado: (2020)

A SARS-CoV-2 familial cluster infection reveals asymptomatic transmission to children
por: Chen, Ming, et al.
Publicado: (2020)

Epidemiological analysis of asymptomatic SARS-CoV-2 transmission in the community: an individual-based model
por: Guo, Zuiyuan, et al.
Publicado: (2021)

SARS-CoV-2 vertical transmission during the first trimester of pregnancy in asymptomatic women
por: Fenizia, Claudio, et al.
Publicado: (2022)

Air contamination with SARS-CoV-2 in the operating room
por: Hirota, Kazuyoshi
Publicado: (2020)

Transmission Cycle of SARS-CoV and SARS-CoV-2
por: Yadav, Tushar, et al.
Publicado: (2020)

Bioinformatical study on the proteomics and evolution of SARS-CoV
por: Liu, Shuqun, et al.
Publicado: (2003)

Tocilizumab in patients infected by SARS-CoV2()
por: Sancho, Milagros, et al.
Publicado: (2021)

Therapeutische Nanobodies gegen SARS-CoV-2
por: Güttler, Thomas, et al.
Publicado: (2022)

Persistent SARS-CoV-2 infection in asymptomatic young adults
por: Ma, Mai-Juan, et al.
Publicado: (2022)

Clinical characteristics of patients with confirmed and asymptomatic SARS-CoV-2 infection in China
por: Li, Zongren, et al.
Publicado: (2022)

SARS-CoV-2 rapid antigen screening of asymptomatic employees: a pilot project
por: Schwartz, Kevin L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k2l8mgqg36g1misnp22vvk5q5f